Press Releases

All Releases
Yield10 Bioscience Announces 1-for-10 Reverse Stock Split
May 26, 2017
WOBURN, Mass. , May 26, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that it will effect a 1-for-10 reverse stock split of its common stock, following stockholder approval of the reverse stock split at the Company's annual stockholders meeting held on May
Yield10 Bioscience Announces First Quarter 2017 Financial Results
May 11, 2017
WOBURN, Mass. , May 11, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today reported financial results for the three months ended March 31, 2017 . Yield10 Bioscience kicked off the year with new branding, reflecting the mission to target the critical unmet need in agriculture
Yield10 Bioscience to Present at Joseph Gunnar Pioneers 2017 Conference
April 27, 2017
WOBURN, Mass. , April 27, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that Lynne Brum , Vice President, Planning and Corporate Communications , will present at the Joseph Gunnar Pioneers 2017 Conference on Tuesday, May 2, 2017 at 9:30 am EDT .
Yield10 Bioscience, Inc. Presentation Now Available for On-Demand Viewing
April 10, 2017
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation WOBURN, Mass. , April 10, 2017 /CNW/ --  Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a company focused on developing new technologies to achieve step-change
Yield10 Bioscience to Host Webcast of its 2016 Year-end Conference Call
March 14, 2017
WOBURN, Mass. , March 14, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that the Company plans to release its fourth quarter 2016 financial results and host a conference call with management after market close on Wednesday, March 22, 2017 .
Yield10 Bioscience to Present at 29th Annual ROTH Conference
March 6, 2017
WOBURN, Mass. , March 06, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that Oliver Peoples , Ph.D., President and Chief Executive Officer, will present at the 29 th Annual ROTH Conference on Wednesday, March 15, 2017 at 9:00 am PT (12:00 noon ET ).
Yield10 Bioscience Expands Scientific Team with Two Key Hires
February 16, 2017
WOBURN, Mass. , Feb. 16, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced that it has expanded its plant science team with two key hires. Karen Bohmert-Tatarev, Ph.D. has joined Yield10 as Technology Manager and Frank Skraly , Ph.D.
Yield10 Bioscience to Host Investor Conference Call
January 24, 2017
WOBURN, Mass. , Jan. 24, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that the Company will host a conference call and live webcast on Thursday, January 26 th  to provide  investors with a presentation on the highlights of the 2016 Camelina Field Test results
Metabolix, Inc. Announces Name Change to Yield10 Bioscience, Inc.  
January 6, 2017
WOBURN, Mass. , Jan. 06, 2017 (GLOBE NEWSWIRE) -- Metabolix, Inc. ( NASDAQ : MBLX), announced today that the Company is changing its name to Yield10 Bioscience, Inc. , effective January 9, 2017 to reflect the new mission and strategic direction of the business.   Yield10 will focus on developing
Displaying 61 - 80 of 87